Here are the S-1 registration statements from Caring Brands, Inc. (CABR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow CABR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CABR filings page.
Caring Brands, Inc. (CABR) registered for resale by selling stockholders up to 24,513,943 shares of common stock: 10,214,143 shares underlying Series B Preferred Stock and 7,149,900 shares under each of the Series A and Series B Warrants. The original conversion price was $0.70 per share; original exercise prices were $0.825 and $0.95 per share, respectively, and are subject to adjustment. The company receives no proceeds from resales or preferred-stock conversions; it may receive cash from cash warrant exercises, while cashless exercises yield no proceeds.
The Series B financing raised gross proceeds of $7,149,900. Common shares outstanding were 10,468,226 as of October 22, 2026.
Caring Brands reported no revenue and a net loss of $2,647,202 for the six months ended June 30, 2026, and a net loss of $6,278,191 for 2025. It says its working-capital deficiency and limited operations raise substantial doubt about its ability to continue as a going concern. Nasdaq issued a delisting determination on July 15, 2026, which the company appealed. The company submitted preliminary, unaudited pro forma equity of $8,220,419 as of August 31, 2026, subject to final accounting and review; Nasdaq had not formally confirmed compliance.
Caring Brands, Inc. has filed a resale registration covering 18,947,370 shares of common stock, all to be offered from time to time by a selling stockholder. These consist of 9,473,685 shares issuable upon conversion of Series A Convertible Preferred Stock and 9,473,685 shares issuable upon exercise of common warrants, each at $0.40 per share.
The company will not receive proceeds from the resale, but could receive about $3.79 million in cash if all warrants are exercised. Caring Brands reports nominal revenues and net losses of $6.28 million for 2025 and $1.52 million for 2024, raising going-concern doubts, and recently received a Nasdaq notice for not meeting the $2.5 million stockholders’ equity requirement. As of the prospectus date, it has 8,941,506 shares outstanding and describes significant risks around liquidity, competition, regulation and product development.